Diabetes

Dec. 7, 2017

Texting Teens and Their Caregivers about Diabetes

Article: J Diabetes Sci Technol. 2017 May;11(3):468-475. NICH at Its Best for Diabetes at Its Worst: Texting Teens and Their Caregivers for Better Outcomes Reviewer: Dr. Sirish Rao

Sept. 24, 2015

Bionic Pancreas for Type 1 Diabetes

Article: N Engl J Med. 2014 Jul 24;371(4):313-25. doi: 10.1056/NEJMoa1314474. Epub 2014 Jun 15. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. Reviewer: Dr. Sajal Patel

June 26, 2014

Acanthosis nigricans in identifying children with dysglycemia

Article: Obesity (Silver Spring). 2013 Mar;21(3):E328-33. doi: 10.1002/oby.20129. The association between acanthosis nigricans and dysglycemia in an ethnically diverse group of eighth grade students. Reviewer: Dr. Rula Khreis

Jan. 23, 2014

Physicians’ Empathy and Clinical Outcomes for Diabetic Patients

Article: Acad Med. 2011 Mar;86(3):359-64. doi: 10.1097/ACM.0b013e3182086fe1. Physicians’ Empathy and Clinical Outcomes for Diabetic Patients Reviewer: Dr. Dana Vietti

Jan. 9, 2014

3-hydroxybutyrate monitoring at home for Type 1 diabetes

Article: Diabet Med. 2006 Mar;23(3):278-84. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial Reviewer: Dr. Eric Neverman

April 11, 2013

Does a DKA protocol help to prevent morbidity?

Article: Crit Care Med. 2007 Jan;35(1):41-6. Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial. Reviewer: Dr. Matt Clark

June 28, 2012

Effect of sodium concentration in IV fluids in DKA

Article: J Clin Res Pediatr Endocrinol. 2011;3(3):149-53. doi: 10.4274/jcrpe.v3i3.29. Efficiency of fluid treatments with different sodium concentration in children with type 1 diabetic ketoacidosis Reviewer: Dr. Andy Ausmus

Feb. 17, 2011

Insulin therapy for newly-diagnosed diabetics

Article: A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes. Reviewer: Dr. Heidi Erickson